89bio, Inc.

NASDAQ:ETNB

8.47 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 0000000
Cost of Revenue 00.2730.240.0790.060.0170.006
Gross Profit 0-0.273-0.24-0.079-0.06-0.017-0.006
Gross Profit Ratio 0000000
Reseach & Development Expenses 345.037122.2380.79670.3336.19921.34613.681
General & Administrative Expenses 39.61928.97421.45319.41313.1565.2941.481
Selling & Marketing Expenses 0000000
SG&A 39.61928.97421.45319.41313.1565.2941.481
Other Expenses 000.242-0.526-0.203-30.562-0.986
Operating Expenses 384.656151.204102.24989.74349.35526.6415.162
Operating Income -384.656-151.204102.249-89.743-49.355-26.64-15.162
Operating Income Ratio 0000000
Total Other Income Expenses Net 18.26912.8820.242-0.526-0.203-30.562-0.986
Income Before Tax -366.387-138.322-102.007-90.269-49.558-57.202-16.148
Income Before Tax Ratio 0000000
Income Tax Expense -0.6923.8670.019-0.147-0.0590.2180.028
Net Income -367.079-142.189-102.026-90.122-49.499-57.42-16.176
Net Income Ratio 0000000
EPS -3.51-2-2.93-4.48-3.08-5.4-3.53
EPS Diluted -3.51-2-2.93-4.48-3.08-5.4-3.53
EBITDA -384.656-134.463-99.845-90.19-49.498-57.185-16.142
EBITDA Ratio 0000000